Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species

Abstract Background Bacteria belonging to the Burkholderia cepacia complex (Bcc) are an important cause of chronic respiratory tract infections in cystic fibrosis patients. Intrinsic resistance to a wide range of antimicrobial agents, including a variety of β-lactam antibiotics, is frequently observ...

Full description

Bibliographic Details
Main Authors: Annelien Everaert, Tom Coenye
Format: Article
Language:English
Published: BMC 2016-11-01
Series:Antimicrobial Resistance and Infection Control
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13756-016-0142-3
id doaj-f71127a8a5974fffbe20396faa988c7b
record_format Article
spelling doaj-f71127a8a5974fffbe20396faa988c7b2020-11-24T21:53:27ZengBMCAntimicrobial Resistance and Infection Control2047-29942016-11-01511810.1186/s13756-016-0142-3Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex speciesAnnelien Everaert0Tom Coenye1Laboratory of Pharmaceutical Microbiology, Ghent UniversityLaboratory of Pharmaceutical Microbiology, Ghent UniversityAbstract Background Bacteria belonging to the Burkholderia cepacia complex (Bcc) are an important cause of chronic respiratory tract infections in cystic fibrosis patients. Intrinsic resistance to a wide range of antimicrobial agents, including a variety of β-lactam antibiotics, is frequently observed in Bcc strains. Resistance to β-lactams is most commonly mediated by efflux pumps, alterations in penicillin-binding proteins or the expression of β-lactamases. β-lactamase inhibitors are able to restore the in vitro activity of β-lactam molecules against a variety of Gram-negative species, but the effect of these inhibitors on the activity of β-lactam treatment against Bcc species is still poorly investigated. Methods In the present study, the susceptibility of a panel of Bcc strains was determined towards the β-lactam antibiotics ceftazidime, meropenem, amoxicillin, cefoxitin, cefepime and aztreonam; alone or in combination with a β-lactamase inhibitor (clavulanic acid, sulbactam, tazobactam and avibactam). Consequently, β-lactamase activity was determined for active β-lactam/β-lactamase inhibitor combinations. Results Clavulanic acid had no effect on minimum inhibitory concentrations, but addition of sulbactam, tazobactam or avibactam to ceftazidime, amoxicillin, cefoxitin, cefepime or aztreonam leads to increased susceptibility (at least 4-fold MIC-decrease) in some Bcc strains. The effect of β-lactamase inhibitors on β-lactamase activity is both strain- and/or antibiotic-dependent, and other mechanisms of β-lactam resistance (besides production of β-lactamases) appear to be important. Conclusions Considerable differences in susceptibility of Bcc strains to β-lactam antibiotics were observed. Results obtained in the present study suggest that resistance of Bcc strains against β-lactam antibiotics is mediated by both β-lactamases and non-β-lactamase-mediated resistance mechanisms.http://link.springer.com/article/10.1186/s13756-016-0142-3Burkholderia cepacia complexResistanceβ-lactamβ-lactamaseβ-lactamase inhibitors
collection DOAJ
language English
format Article
sources DOAJ
author Annelien Everaert
Tom Coenye
spellingShingle Annelien Everaert
Tom Coenye
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
Antimicrobial Resistance and Infection Control
Burkholderia cepacia complex
Resistance
β-lactam
β-lactamase
β-lactamase inhibitors
author_facet Annelien Everaert
Tom Coenye
author_sort Annelien Everaert
title Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
title_short Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
title_full Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
title_fullStr Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
title_full_unstemmed Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
title_sort effect of β-lactamase inhibitors on in vitro activity of β-lactam antibiotics against burkholderia cepacia complex species
publisher BMC
series Antimicrobial Resistance and Infection Control
issn 2047-2994
publishDate 2016-11-01
description Abstract Background Bacteria belonging to the Burkholderia cepacia complex (Bcc) are an important cause of chronic respiratory tract infections in cystic fibrosis patients. Intrinsic resistance to a wide range of antimicrobial agents, including a variety of β-lactam antibiotics, is frequently observed in Bcc strains. Resistance to β-lactams is most commonly mediated by efflux pumps, alterations in penicillin-binding proteins or the expression of β-lactamases. β-lactamase inhibitors are able to restore the in vitro activity of β-lactam molecules against a variety of Gram-negative species, but the effect of these inhibitors on the activity of β-lactam treatment against Bcc species is still poorly investigated. Methods In the present study, the susceptibility of a panel of Bcc strains was determined towards the β-lactam antibiotics ceftazidime, meropenem, amoxicillin, cefoxitin, cefepime and aztreonam; alone or in combination with a β-lactamase inhibitor (clavulanic acid, sulbactam, tazobactam and avibactam). Consequently, β-lactamase activity was determined for active β-lactam/β-lactamase inhibitor combinations. Results Clavulanic acid had no effect on minimum inhibitory concentrations, but addition of sulbactam, tazobactam or avibactam to ceftazidime, amoxicillin, cefoxitin, cefepime or aztreonam leads to increased susceptibility (at least 4-fold MIC-decrease) in some Bcc strains. The effect of β-lactamase inhibitors on β-lactamase activity is both strain- and/or antibiotic-dependent, and other mechanisms of β-lactam resistance (besides production of β-lactamases) appear to be important. Conclusions Considerable differences in susceptibility of Bcc strains to β-lactam antibiotics were observed. Results obtained in the present study suggest that resistance of Bcc strains against β-lactam antibiotics is mediated by both β-lactamases and non-β-lactamase-mediated resistance mechanisms.
topic Burkholderia cepacia complex
Resistance
β-lactam
β-lactamase
β-lactamase inhibitors
url http://link.springer.com/article/10.1186/s13756-016-0142-3
work_keys_str_mv AT annelieneveraert effectofblactamaseinhibitorsoninvitroactivityofblactamantibioticsagainstburkholderiacepaciacomplexspecies
AT tomcoenye effectofblactamaseinhibitorsoninvitroactivityofblactamantibioticsagainstburkholderiacepaciacomplexspecies
_version_ 1725872123309719552